Which of the following is a new oral drug approved for Rheumatoid ahritis?
UPADACITINIB : - It is an oral JAK 1 inhibitors like tofacitinib - Used for Rheumatoid ahritis to slow down the disease progression. FEDRATINIB : - It is a oral JAK 2 inhibitor . - Used for MYELOFIBROSIS ENTRECTINIB : - It is oral Tyrosine kinase inhibitor. - Used for ROS - 1 positive NON SMALL CELL LUNG CANCER and NK positive solid tumors. TALAZOPARIB : - PARP inhibitor like olaparib - Used for breast cancer.
UPADACITINIB
FEDRATINIB
ENTRECTINIB
TALAZOPARIB
NSAIDs, Gout and Rheumatoid Ahritis